These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 19962456)

  • 21. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 1.
    Kelly G
    Altern Med Rev; 2010 Sep; 15(3):245-63. PubMed ID: 21155626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calorie restriction, SIRT1 and metabolism: understanding longevity.
    Bordone L; Guarente L
    Nat Rev Mol Cell Biol; 2005 Apr; 6(4):298-305. PubMed ID: 15768047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SIRT1 and insulin resistance.
    Cao Y; Jiang X; Ma H; Wang Y; Xue P; Liu Y
    J Diabetes Complications; 2016; 30(1):178-83. PubMed ID: 26422395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sirtuins: novel targets for metabolic disease in drug development.
    Jiang WJ
    Biochem Biophys Res Commun; 2008 Aug; 373(3):341-4. PubMed ID: 18577374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue-specific regulation of sirtuin and nicotinamide adenine dinucleotide biosynthetic pathways identified in C57Bl/6 mice in response to high-fat feeding.
    Drew JE; Farquharson AJ; Horgan GW; Williams LM
    J Nutr Biochem; 2016 Nov; 37():20-29. PubMed ID: 27592202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.
    Pacholec M; Bleasdale JE; Chrunyk B; Cunningham D; Flynn D; Garofalo RS; Griffith D; Griffor M; Loulakis P; Pabst B; Qiu X; Stockman B; Thanabal V; Varghese A; Ward J; Withka J; Ahn K
    J Biol Chem; 2010 Mar; 285(11):8340-51. PubMed ID: 20061378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age-associated loss of Sirt1-mediated enhancement of glucose-stimulated insulin secretion in beta cell-specific Sirt1-overexpressing (BESTO) mice.
    Ramsey KM; Mills KF; Satoh A; Imai S
    Aging Cell; 2008 Jan; 7(1):78-88. PubMed ID: 18005249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vino veritas: a tale of two sirt1s?
    Koo SH; Montminy M
    Cell; 2006 Dec; 127(6):1091-3. PubMed ID: 17174885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2.
    Kelly GS
    Altern Med Rev; 2010 Dec; 15(4):313-28. PubMed ID: 21194247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of sirtuins: new targets for antiageing.
    Pallàs M; Verdaguer E; Tajes M; Gutierrez-Cuesta J; Camins A
    Recent Pat CNS Drug Discov; 2008 Jan; 3(1):61-9. PubMed ID: 18221243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Emerging Role of SIRT7 in Glucose and Lipid Metabolism.
    Yamagata K; Mizumoto T; Yoshizawa T
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats.
    Ding S; Jiang J; Zhang G; Bu Y; Zhang G; Zhao X
    PLoS One; 2017; 12(8):e0183541. PubMed ID: 28817690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sirtuins, aging, and metabolism.
    Guarente L
    Cold Spring Harb Symp Quant Biol; 2011; 76():81-90. PubMed ID: 22114328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.
    Lagouge M; Argmann C; Gerhart-Hines Z; Meziane H; Lerin C; Daussin F; Messadeq N; Milne J; Lambert P; Elliott P; Geny B; Laakso M; Puigserver P; Auwerx J
    Cell; 2006 Dec; 127(6):1109-22. PubMed ID: 17112576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SIRT1 and other sirtuins in metabolism.
    Chang HC; Guarente L
    Trends Endocrinol Metab; 2014 Mar; 25(3):138-45. PubMed ID: 24388149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anti-aging, metabolism potential of SIRT1.
    Ghosh HS
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1095-102. PubMed ID: 18821472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease.
    Colak Y; Ozturk O; Senates E; Tuncer I; Yorulmaz E; Adali G; Doganay L; Enc FY
    Med Sci Monit; 2011 May; 17(5):HY5-9. PubMed ID: 21525818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic lipid metabolic pathways modified by resveratrol in rats fed an obesogenic diet.
    Alberdi G; Rodríguez VM; Macarulla MT; Miranda J; Churruca I; Portillo MP
    Nutrition; 2013 Mar; 29(3):562-7. PubMed ID: 23274094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirtuins and renal diseases: relationship with aging and diabetic nephropathy.
    Kitada M; Kume S; Takeda-Watanabe A; Kanasaki K; Koya D
    Clin Sci (Lond); 2013 Feb; 124(3):153-64. PubMed ID: 23075334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross talk between angiotensin-(1-7)/Mas axis and sirtuins in adipose tissue and metabolism of high-fat feed mice.
    Oliveira Andrade JM; Paraíso AF; Garcia ZM; Ferreira AV; Sinisterra RD; Sousa FB; Guimarães AL; de Paula AM; Campagnole-Santos MJ; dos Santos RA; Santos SH
    Peptides; 2014 May; 55():158-65. PubMed ID: 24642355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.